South Korea vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
South Korea
0
in 2018
New Zealand
0.1
in 2020
South Korea rank
13th
New Zealand rank
11th
Proportion of isolates with decreased susceptibility or resistance over time
- South Korea
- New Zealand
How they compare
New Zealand currently reports 0.1 against 0 in South Korea, a difference of 0.1.
The two have swapped places 1 time across 8 shared years of data; in 2009 it was South Korea ahead.
South Korea ranks 13th and New Zealand ranks 11th of 52 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.27 | 0 | 29.27 | South Korea |
| 2010s | 17.9 | 0.4109 | 17.49 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, South Korea or New Zealand?
- New Zealand, at 0.1 against 0 in South Korea as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between South Korea and New Zealand?
- 0.1, with New Zealand ahead.
- How many years of comparable data are there for South Korea and New Zealand?
- 8 years are reported by both, from 2009 to 2017.
- How do South Korea and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- South Korea ranks 13th and New Zealand ranks 11th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.